The therapeutic effects of adipose-derived mesenchymal stem cells on obesity and its associated diseases in diet-induced obese mice

dc.contributor.authorJaber, Hala
dc.contributor.authorIssa, Khodr
dc.contributor.authorEid, Ali H.
dc.contributor.authorSaleh, Fatima A.
dc.contributor.departmentPharmacology and Toxicology
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:39:50Z
dc.date.available2025-01-24T11:39:50Z
dc.date.issued2021
dc.description.abstractObesity is a global public health concern associated with increased risk of several comorbidities. Due to the limited effectiveness of current therapies, new treatment strategies are needed. Our aim was to examine the effect of adipose-derived mesenchymal stem cells (AD-MSCs) on obesity and its associated diseases in a diet-induced obese (DIO) animal model. C57BL6 mice were fed with either high fat diet (HFD) or CHOW diet for 15 weeks. Obese and lean mice were then subjected to two doses of AD-MSCs intraperitoneally. Mice body weight and composition; food intake; blood glucose levels; glycated hemoglobin (HbA1c), intraperitoneal glucose tolerance test and atherogenic index of plasma (AIP) were measured. Pro-inflammatory cytokines, tumor necrosis factor-α and interleukin-6, were also determined. AD-MSCs treatment reduced blood glucose levels, HbA1c and AIP as well as improved glucose tolerance in DIO mice. In addition, MSCs caused significant attenuation in the levels of inflammatory mediators in HFD-fed mice. Taken together, AD-MSCs were effective in treating obesity-associated diabetes in an animal model as well as protective against cardiovascular diseases as shown by AIP, which might be partly due to the attenuation of inflammatory mediators. Thus, AD-MSCs may offer a promising therapeutic potential in counteracting obesity-related diseases in patients. © 2021, The Author(s).
dc.identifier.doihttps://doi.org/10.1038/s41598-021-85917-9
dc.identifier.eid2-s2.0-85102732980
dc.identifier.pmid33737713
dc.identifier.urihttp://hdl.handle.net/10938/29366
dc.language.isoen
dc.publisherNature Research
dc.relation.ispartofScientific Reports
dc.sourceScopus
dc.subjectAdipose tissue
dc.subjectAnimals
dc.subjectBlood glucose
dc.subjectBody weight
dc.subjectCardiovascular diseases
dc.subjectCells, cultured
dc.subjectDiabetes complications
dc.subjectDiet, high-fat
dc.subjectDisease models, animal
dc.subjectGlucose tolerance test
dc.subjectGlycated hemoglobin a
dc.subjectHumans
dc.subjectInfusions, parenteral
dc.subjectMale
dc.subjectMesenchymal stem cell transplantation
dc.subjectMice
dc.subjectMice, inbred c57bl
dc.subjectObesity
dc.subjectTreatment outcome
dc.subjectGlycosylated hemoglobin
dc.subjectAdverse event
dc.subjectAnimal
dc.subjectC57bl mouse
dc.subjectCardiovascular disease
dc.subjectCell culture
dc.subjectComplication
dc.subjectCytology
dc.subjectDiabetic complication
dc.subjectDisease model
dc.subjectGlucose blood level
dc.subjectHuman
dc.subjectLipid diet
dc.subjectMouse
dc.subjectParenteral drug administration
dc.subjectProcedures
dc.titleThe therapeutic effects of adipose-derived mesenchymal stem cells on obesity and its associated diseases in diet-induced obese mice
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2021-5884.pdf
Size:
1.38 MB
Format:
Adobe Portable Document Format